Congratulations Dr. Draaisma

$60,100 awarded thanks to our community riders and supporters matched by Penn ODC

Dr. Jos M Draaisma, MD PhD, Radboud University Medical Center

Project Title: The central conducting lymphatic system in patients with the Rasopathies Noonan Syndrome and CardioFacioCutaneous Syndrome with and without lymphatic disease

MDBR OFFICIAL ANNOUNCEMENT

~ PAST AWARDEES ~

2022: Fabrice Jaffré, PhD, Weill Cornell Medical College, $75,431
Discovery of new therapies for hypertrophic cardiomyopathy in RASopathies using an innovative hiPSC-based high throughput drug screening platform

2021: Vanessa Fear, BSc (Hons), PhD, The University of Western Australia, Telethon Kids Institute, $69,885
Understanding RASopathies to better inform diagnosis and treatment

2020: Gregor Andelfinger, MD PhD, CHU Sainte Justine Research Center, Université de Montréal, $59,220
MEK inhibition for RASopathy associated hypertrophic cardiomyopathy

2019: Bruce Gelb, MD, Icahn School of Medicine at Mt. Sinai, NY , $74,830
Advancing A Novel Therapeutic Lead for RASopathies 

2018: Kartik Venkatachalam, PhD, McGovern Medical School, University of Texas Science Center at Houston, $47,189
Targeting Endolysosomal Proteins to Treat RASopathies 

2017: Philip Stork, MD, Oregon Health Sciences University, $44,000
Are Raf dimers targets for therapeutic intervention in RASopathies?

2016: Giuseppe Zampino, Università Cattolica Sacro Cuore, $53,000
Pain in RASopathies: new investigative techniques and treatments

2015: Maria Kontaridis, PhD, Beth Israel Deaconess Medical Center/Harvard Medical School, $65,000
Pilot study to delineate the cause of gastrointestinal abnormalities in RASopathy disorders using human inducible pluripotent stem cells (iPSCs)